AdheriumASX:ADR -25.00%8 14-Day RSI is 33.34 as of Jul. 09, 2026. GuruFocus rates ASX:ADR with a GF Score™ of 8/100 and a GF Value™ of A$0.35 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 868 Medical Devices & Instruments companies, Adherium ranks worse than 59.1% on this metric.
The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.
As of today (2026-07-09), Adherium's 14-Day RSI is 33.34.
The industry rank for Adherium's 14-Day RSI or its related term are showing as below:
ASX:ADR's 14-Day RSI is ranked worse than 59.1% of 868
companies
in the Medical Devices & Instruments industry
Industry Median: 46.86
vs ASX:ADR: 33.34
Adherium (ASX:ADR) 14-Day RSI Explanation
The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.
Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.
RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.
Adherium 14-Day RSI Related Terms
ASX:ADR vs ABT, SYK, MDT: 14-Day RSI Comparison
For the Medical Devices subindustry, Adherium's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Adherium 14-Day RSI vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Adherium's 14-Day RSI distribution charts can be found below:
* The bar in red indicates where Adherium's 14-Day RSI falls into.
* Note that the formula uses a positive value for the average loss.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Adherium (ASX:ADR) has a 14-Day RSI of 33.34 as of Jul. 09, 2026. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Adherium and its competitors. According to the industry distribution chart, Adherium ranks #513 out of 868 companies in the Medical Devices & Instruments industry, placing it in the top 59.1%.
Is Adherium's 14-Day RSI too high?
Adherium's current 14-Day RSI is 33.34. The Medical Devices & Instruments industry median 14-Day RSI is 46.86. Adherium's value of 33.34 is 28.9% below this industry median. Based on the distribution chart, Adherium ranks #513 out of 868 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Adherium has a GF Score™ of 8/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adherium's 14-Day RSI compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Adherium ranks #513 out of 868 companies for 14-Day RSI. This places Adherium in the lower half of its industry. The industry median 14-Day RSI is 46.86. Adherium's value of 33.34 is 28.9% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 14-Day RSI for a Medical Devices & Instruments company?
The median 14-Day RSI among Medical Devices & Instruments companies is 46.86, based on 868 companies in the industry. Companies in the top quartile (top 25%) have a 14-Day RSI significantly above this median, while those in the bottom quartile fall well below. However, 14-Day RSI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Adherium's current 14-Day RSI of 33.34 is 28.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 14-Day RSI mean?
A high 14-Day RSI can signal that a stock is expensive relative to its fundamentals. Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. View historical data on Adherium and its competitors. For the Medical Devices & Instruments industry, the median 14-Day RSI is 46.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Adherium's current 14-Day RSI is 33.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adherium stock overvalued right now?
Based on GuruFocus' analysis, Adherium (ASX:ADR) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.35, compared to a current price of A$0.15 — trading 57.1% below its estimated fair value. The current 14-Day RSI is 33.34 and 28.9% below the Medical Devices & Instruments industry median of 46.86. Adherium's overall GF Score™ is 8/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 14-Day RSI calculated?
14-Day RSI is calculated from a company's financial statements. For Adherium (ASX:ADR), the current 14-Day RSI is 33.34 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Adherium (ASX:ADR) Overvalued in 2026?
Based on GuruFocus' analysis, Adherium stock appears to be undervalued.
The current stock price of A$0.15 is trading 57.1% below its estimated GF Value™ of A$0.35.
GuruFocus considers Adherium to be Possible Value Trap.
Key valuation signals for ASX:ADR:
14-Day RSI: 33.34
GF Value™: A$0.35 vs. price of A$0.15 (57.1% below fair value)
Industry Position: 28.9% below the Medical Devices & Instruments median (#513 of 868)
No single metric tells the full story. See the ASX:ADR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Adherium Ltd is engaged in the development, manufacture, and supply of its Hailie digital health technologies that address sub-optimal medication use and improve health outcomes in chronic disease. It is an international Respiratory eHealth company focused on patient medication adherence, remote monitoring, and data management solutions for patients, payers, and providers. Its geographically segments include New Zealand and Australia, Europe, North America, and Asia. The majority of its revenue comes from Europe.
8GF Score
Get the complete analysis for ASX:ADR
14-Day RSI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:ADR has been successfully added to your 